E. Chatelus

Most-cited papers

1. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

   Pierre-Louis Gilles Arthur Xavier Olivier Matthieu Raphael Phil Tharaux Pialoux Pavot Mariette Hermine Resche-Rigo, P. Tharaux, Gilles Pialoux, Arthur Pavot +496 more

   2021The Lancet Respiratory Medicine243 citations Open access

   Semantic Scholar

   Save

2. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.

   M. Scherlinger, P. Mertz, F. Sagez, A. Meyer +15 more

   2020Autoimmunity Reviews126 citations Open access

   Semantic Scholar

   Save

3. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020

   C. Kaeuffer, C. Le Hyaric, Thibaut Fabacher, J. Mootien +74 more

   2020Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin102 citations Open access

   Semantic Scholar

   Save

4. Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases

   R. Felten, Maxime Dubois, M. Ugarte-Gil, A. Chaudier +12 more

   2021The Lancet Rheumatology89 citations Open access

   Semantic Scholar

   Save

5. A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients

   A. Mariotte, Aurore De Cauwer, C. Po, Chérine Abou-Faycal +11 more

   2020Theranostics50 citations Open access

   Semantic Scholar

   Save

6. Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

   R. Felten, F. Gallais, C. Schleiss, E. Chatelus +7 more

   2021The Lancet Rheumatology40 citations Open access

   Semantic Scholar

   Save

7. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

   M. Scherlinger, L. Pijnenburg, E. Chatelus, L. Arnaud +3 more

   2021Vaccines39 citations Open access

   Semantic Scholar

   Save

8. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

   Xavier Olivier Pierre-Louis Matthieu Raphael Philippe Ser Mariette Hermine Tharaux Resche-Rigon Porcher Rava, Xavier Mariette, O. Hermine, P. Tharaux +496 more

   2021The Lancet Rheumatology38 citations Open access

   Semantic Scholar

   Save

9. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study.

   D. Farge, Ś. Loisel, M. Resche-Rigon, P. Lansiaux +16 more

   2022The Lancet Rheumatology33 citations Open access

   Semantic Scholar

   Save

10. Refining long-COVID by a prospective multimodal evaluation of patients with long-term symptoms related to SARS-CoV-2 infection

    M. Scherlinger, R. Felten, F. Gallais, C. Nazon +16 more

    2021medRxiv29 citations Open access

    Semantic Scholar

    Save

11. Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

    M. Scherlinger, R. Felten, F. Gallais, C. Nazon +16 more

    2021Infectious Disease and Therapy29 citations Open access

    Semantic Scholar

    Save

12. Cluster analysis reveals 3 main patterns of behavior towards SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases

    R. Felten, Maxime Dubois, M. Ugarte-Gil, A. Chaudier +12 more

    2021Rheumatology26 citations Open access

    Semantic Scholar

    Save

13. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments.

    M. Scherlinger, J. Lutz, G. Galli, C. Richez +7 more

    2020Seminars in Arthritis & Rheumatism26 citations Open access

    Semantic Scholar

    Save

14. Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature.

    Clara Pouchelon, M. Visentini, G. Emmi, V. Le Guern +18 more

    2022Autoimmunity Reviews20 citations Open access

    Semantic Scholar

    Save

15. B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

    R. Felten, P. Duret, É. Bauer, N. Sedmak +25 more

    2021Annals of the Rheumatic Diseases17 citations

    Semantic Scholar

    Save

16. Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment

    C. Bruni, S. Heidenreich, A. Duenas, A. Hoffmann-Vold +14 more

    2022Rheumatology14 citations Open access

    Semantic Scholar

    Save

17. Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.

    D. Levy, B. Nespola, M. Giannini, R. Felten +17 more

    2021Rheumatology14 citations

    Semantic Scholar

    Save

18. Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

    Marc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, E. Chatelus +13 more

    2026Annals of the Rheumatic Diseases11 citations Open access

    Semantic Scholar

    Save

19. Heart and systemic sclerosis-findings from a national cohort study.

    A. Guédon, Fabrice Carrat, L. Mouthon, D. Launay +30 more

    2023Rheumatology11 citations

    Semantic Scholar

    Save

20. Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016–2017

    P. Richebé, G. Coiffier, P. Guggenbuhl, D. Mulleman +27 more

    2022Annals of the Rheumatic Diseases10 citations Open access

    Semantic Scholar

    Save

21. Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

    R. Felten, M. Scherlinger, A. Guffroy, V. Poindron +13 more

    2021Arthritis Research & Therapy9 citations Open access

    Semantic Scholar

    Save

22. Influence of systemic sclerosis on periodontal health: A case-control study.

    Sophie Jung, Marianna Gavriiloglou, F. Séverac, Lucille Haumesser +4 more

    2023Journal of Clinical Periodontology8 citations Open access

    Semantic Scholar

    Save

23. How and why are rheumatologists relevant to COVID-19?

    R. Felten, E. Chatelus, L. Arnaud

    2020Joint Bone Spine7 citations Open access

    Semantic Scholar

    Save

24. Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc).

    François Barde, K. Chevalier, Paul Decker, Matéo Merin +19 more

    2025Journal of Autoimmunity6 citations Open access

    Semantic Scholar

    Save

25. An updated overview of Juvenile systemic sclerosis in a French cohort

    L. Jacquel, Rouba Bechara, J. Terzic, A. Rameau +11 more

    2025Pediatric Rheumatology Online Journal6 citations Open access

    Semantic Scholar

    Save

26. Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study

    B. Chaigne, Alexandre Bense, C. Agard, Y. Allanore +40 more

    2023Journal of Internal Medicine6 citations

    Semantic Scholar

    Save

27. Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study.

    B. Chaigne, Alexandre Bense, F. Aubourg, C. Agard +17 more

    2025Journal of Autoimmunity5 citations Open access

    Semantic Scholar

    Save

28. Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

    A. Guédon, Fabrice Carrat, L. Mouthon, D. Launay +32 more

    2024RMD Open5 citations Open access

    Semantic Scholar

    Save

29. METHOFRACT, a methotrexate osteopathy multicentre cohort study

    François Robin, Roba Ghossan, N. Mehsen-Cêtre, L. Triquet +33 more

    2025RMD Open4 citations Open access

    Semantic Scholar

    Save

30. Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study

    Cécile Trottet, Manuel Schürch, A. Allam, L. Petelytska +133 more

    2025npj Digital Medicine4 citations Open access

    Semantic Scholar

    Save

31. Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study.

    A. Murarasu, Lauren Beaudeau, V. Le Guern, G. Guettrot-Imbert +29 more

    2025The Lancet Rheumatology4 citations Open access

    Semantic Scholar

    Save

32. Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

    R. Felten, T. Fabacher, N. Sedmak, Jean Sibilia +8 more

    2024Journal of Clinical Medicine3 citations Open access

    Semantic Scholar

    Save

33. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

    Elisabeth Deibel, P. Carreira, M. Vonk, N. Del Papa +60 more

    2023Arthritis care & research3 citations Open access

    Semantic Scholar

    Save

34. POS1121 THE USE OF THE CD3/CD19 T CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS: A CASE SERIES

    M. Scherlinger, Y. Dieudonne, A. Moltó, E. Chatelus +9 more

    2025Annals of the Rheumatic Diseases2 citations Open access

    Semantic Scholar

    Save

35. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

    J. Gottenberg, A. Chaudier, Y. Allenbach, Arsène M. Mékinian +43 more

    2022RMD Open2 citations Open access

    Semantic Scholar

    Save

36. Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: a case series.

    S. Demuth, R. Felten, C. Sordet, E. Chatelus +2 more

    2021Joint Bone Spine2 citations

    Semantic Scholar

    Save

37. O5 Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

    M. Scherlinger, P. Mertz, F. Sagez, A. Meyer +15 more

    20202 citations Open access

    Semantic Scholar

    Save

38. Biomédicaments et thérapies ciblées par de petites molécules immunosuppressives

    R. Felten, F. Sagez, L. Arnaud, E. Chatelus +6 more

    2020International Conference on Embedded and Multimedia Computing2 citations

    Semantic Scholar

    Save

39. Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

    R. Felten, M. Geoffroy, Loïs Bolko, P. Duret +15 more

    2022Joint Bone Spine1 citations Open access

    Semantic Scholar

    Save

40. Prévalence du COVID-19 et des poussées inflammatoires chez les patients atteints de maladie auto-immunes systémiques rares : enquête systématique téléphonique et sérologique dans un centre national de référence

    R. Felten, M. Scherlinger, J. Kleinmann, C. Sordet +11 more

    20201 citations

    Semantic Scholar

    Save

41. OC.53 Use of the CD19/CD3 T cell engager blinatumomab in refractory systemic sclerosis: a case series

    J. Avouac, Marc Scherlinger, J. Decroocq, Yannick Dieudonné +9 more

    2026Oral Communications0 citations Open access

    Semantic Scholar

    Save

42. Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas.

    S. Jousse-Joulin, M. D'Agostino, G. Mouterde, E. Naredo +40 more

    2026Rheumatology0 citations

    Semantic Scholar

    Save

43. OC.10 Association between vasoactive-vasodilating therapy and reduced detection of pulmonary arterial hypertension in systemic sclerosis: evidence from a EUSTAR study

    N. Farina, S. Bellando-Randone, S. Sanges, Hilde Jenssen Bjørkekjær +22 more

    2026Oral Communications0 citations Open access

    Semantic Scholar

    Save

44. P.405 Clinical characteristics and ethnic differences in anti-fibrillarin positive systemic sclerosis patients: an international multicenter cohort study

    R. D'Alessandro, Stefano Rodolfi, Ami A. Shah, L. Hummers +23 more

    2026Poster Presentations0 citations Open access

    Semantic Scholar

    Save

45. Évaluation de l’association Mycophénolate mofétil – Rituximab dans la sclérodermie systémique : étude rétrospective multicentrique française

    F. Bardé, K. Chevalier, P. Decker, M. Merín +19 more

    2026La Revue de Médecine Interne0 citations

    Semantic Scholar

    Save

46. La capacité pulmonaire totale est prédictive de la sévérité de la maladie et de la survie dans la sclérodermie systémique : une analyse longitudinale chez 2347 patients de l’étude de cohorte nationale française

    B. Chaigne, A. Bense, F. Aubourg, C. Agard +17 more

    2025La Revue de Médecine Interne0 citations

    Semantic Scholar

    Save

47. Utilisation du blinatumomab, un T-cell engager CD3/CD19, dans la sclérodermie systémique réfractaire : une série multicentrique

    M. Scherlinger, Y. Dieudonné, E. Chatelus, J. Decroocq +10 more

    2025Revue du Rhumatisme0 citations

    Semantic Scholar

    Save

48. ABS0554 FEATURES OF ANTI-FIBRILLARIN POSITIVE SYSTEMIC SCLEROSIS PATIENTS AND ETHNIC DIFFERENCES: A EUROPEAN MULTICENTRIC COHORT

    R. D’Alessandro, S. Rodolfi, A. Calot, L. Bébéar +19 more

    2025Annals of the Rheumatic Diseases0 citations Open access

    Semantic Scholar

    Save

49. POS0635 RELIABILITY OF ELEMENTARY ULTRASONOGRAPHIC LESIONS IN PSORIATIC ARTHRITIS AND DEVELOPMENT OF AN ATLAS: RESULTS OF THE ECHO-APACHE STUDY

    S. Jousse-Joulin, M. D'Agostino, G. Mouterde, E. Naredo +40 more

    2025Annals of the Rheumatic Diseases0 citations Open access

    Semantic Scholar

    Save

50. Néoehrlichiose chez deux patients sous anti-CD20 : une cause méconnue de fièvre prolongée

    T. Subervie, L. Kawka, J. Gottenberg, L. Arnaud +14 more

    2025Revue du Rhumatisme0 citations

    Semantic Scholar

    Save